DrugPatentWatch Database Preview
Portola Pharms Inc Company Profile
What is the competitive landscape for PORTOLA PHARMS INC, and when can generic versions of PORTOLA PHARMS INC drugs launch?
PORTOLA PHARMS INC has one approved drug.
There are ten US patents protecting PORTOLA PHARMS INC drugs.
There are one hundred and twenty-one patent family members on PORTOLA PHARMS INC drugs in thirty-one countries.
Summary for Portola Pharms Inc
| International Patents: | 121 |
| US Patents: | 10 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Portola Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | 6,376,515 | Start Trial | Y | Y | Start Trial | ||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-001 | Jun 23, 2017 | RX | Yes | No | 8,518,977 | Start Trial | Y | Start Trial | |||
| Portola Pharms Inc | BEVYXXA | betrixaban | CAPSULE;ORAL | 208383-002 | Jun 23, 2017 | RX | Yes | Yes | 6,835,739 | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Portola Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 4535301 | Start Trial |
| South Korea | 20090107499 | Start Trial |
| Denmark | 1948608 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
